For decades, cancer immunotherapy has focused primarily on CD8+ cytotoxic T lymphocytes as the main executors of tumor cell ...
A research team led by Albert Einstein College of Medicine scientists has developed a new strategy to engineer immune cells ...
In MS trials, investigators are steering those cells toward B‑cell populations that appear to be driving inflammation.
Tumour reactive T cells identified through transcriptional profiling predict response to multiple myeloma immunotherapy and ...
Researchers at the Kennedy Institute of Rheumatology have found that physically resisting the formation of an immunological synapse actually promotes a stronger immune response. The findings could ...
MB-105, a CD5-targeted CAR-T cell therapy, has received FDA regenerative medicine advanced therapy designation for relapsed/refractory CD5-positive T-cell lymphoma. The designation aims to expedite ...
A research team led by Albert Einstein College of Medicine scientists has developed a new strategy to engineer immune cells ...
Chronic diabetic ulcers represent one of the most challenging complications in modern healthcare, affecting over 131 million people worldwide and generating approximately $755 billion in annual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results